European Addiction Research
September 25, 2024
Ioanna A. Vamvakopoulou, David Nutt
13 citations
Background: Psychedelic substance use in ritualistic and ceremonial settings dates back as early as 8,500 BCE. Only in recent years, from the mid-20th century, we have seen the re-emergence of psychedelics in a therapeutic setting and more specifically for the treatment of addiction. This article aims to review research over the past 40 years using classic (psilocybin, lysergic acid...
European Addiction Research
2024
Ruben Johannes Jacob Van Beek, Matthijs Blankers, Marloes Kleinjan et al.
3 citations
Polydrug use patterns among young adults using ecstasy vary, as well as their willingness to change them. Polydrug use patterns are likely associated with different adverse health outcomes. It is unknown whether polydrug use patterns of young adults who use ecstasy are similar in different countries. This study aims to identify and compare polydrug use patterns and willingness to change them of...
European Addiction Research
2024
Anne-Sophie Derne, Jean-Yves Jouzeau, Elise Pape et al.
Hexahydrocannabinol or HHC has recently appeared on the Internet and in cannabidiol (CBD) stores in various forms. Although the abuse and dependence potential of HHC consumption has not yet been established, HHC has been reported by consumers to have effects similar to delta-9-tetrahydrocannabinol (THC) and has been classified as narcotics in France since June 12, 2023. We conducted a...
European Addiction Research
2021
Matthijs Blankers, Daan van der Gouwe, Lavinia Stegemann et al.
21 citations
In this article, we present an evaluation of online psychoactive substance trade via Telegram, a free encrypted social media messenger service. The evaluation took place during the COVID-19 pandemic, which allowed us to monitor the effects of the spring 2020 lockdown in the Netherlands on substance trade via Telegram. The objective of this study was to evaluate whether changes in psychoactive...
European Addiction Research
2020
Franz Moggi, Deborah Schorno, Leila M. Soravia et al.
22 citations
<b><i>Background:</i></b> Attention deficit/hyperactivity disorder (ADHD), conduct disorder (CD), and sensation seeking (SS) have been consistently related to a higher risk of substance use (SU) and substance use disorder (SUD). <b><i>Objectives:</i></b> To investigate the relationship between ADHD and prevalence rates in males at age 20 and age 25, the initiation of SU and SUD after age 20,...
European Addiction Research
December 18, 2006
Jim Mccambridge, Adam Winstock, Neil Hunt et al.
113 citations
<i>Aims:</i> To describe and assess trends in the use of hallucinogens and other adjunct drugs over a 5-year period. <i>Design:</i> Repeated-measures cross-sectional survey. <i>Setting and Participants:</i> Annual magazine-based survey targeting people who use drugs in dance contexts. <i>Measurements:</i> Lifetime use prevalence (ever used); age of first use; current use prevalence (any use...
European Addiction Research
2002
Julio Bobes, Pilar A. Sáiz, María Paz García‐portilla et al.
34 citations
<i>Aim: </i>To measure the prevalence of 3,4-methylenedioxymethamphetamine (MDMA) and other drug use in young males entering compulsory military service in Asturias (northern Spain) and to define trends in MDMA use in this group during the period from 1995 to 1999. We also sought to determine whether MDMA users have distinct personality features or higher levels of sensation seeking....
European Addiction Research
June 1, 1999
D Basu, A Malhotra, A Bhagat et al.
Twenty cases of cannabis psychosis were compared with a control group of 20 patients with 'acute schizophrenic episode' on a number of demographic, clinical, illness-related and outcome variables in a case-control study design using a retrospective chart review. The two groups were comparable on demographic, past and family histories of mental illness, premorbid personality, psychomotor...
European Addiction Research
1998
Peter Schuster, Roselind Lieb, Christina Maria Lamertz et al.
96 citations
This report presents findings of a community survey of 3,021 adolescents and young adults aged 14–24 years in Munich, Germany, carried out to determine the prevalence of use and abuse of and dependence on ecstasy, amphetamines and hallucinogens. The response rate was 71%. <b>Results:</b> (1) In 1995, 4% of the male and 2.3% of the female respondents aged 14–24 reported the use of ecstasy....